Preview

Epidemiology and Vaccinal Prevention

Advanced search

Trends in the dynamics of morbidity and mortality from COVID-19 in Russia (2020-2025)

https://doi.org/10.31631/2073-3046-2025-24-5-4-23

Abstract

Relevance. The study COVID-19 is due to its continued circulation in SARS-CoV-2 in the world and the beginning of an increase cases in Russia this season. 
Aims. To compare the trends of the COVID-19 epidemic process in terms of morbidity and mortality in epidemic and inter-epidemic periods among the Russian population. 
Materials and methods. The analysis of the incidence and mortality of COVID-19 in Russia, megacities and 54 cities was carried out according to the стопкоронавирус. рф and the computer database of the Influenza Research Institute. 
Results. In Russia, 9 epidemics of COVID-19 and 4 inter-epidemic periods have been egistered in 5 years, the first in the summer of 2022, then in 2023, 2024 and in 2025 (from January to May). There are similar trends in reducing morbidity and mortality in epidemics and inter–epidemic periods: at the same time, the dynamics of epidemics shows an increase in morbidity in the first 5 waves, and from the sixth – a decrease, and an increase in mortality with a peak in the fourth wave, and in the fifth – a decrease in mortality to a minimum in the ninth wave. In the dynamics of epidemics in St. Petersburg, 54 cities and the Russian Federation as a whole, the coefficients of the trend of increasing morbidity were lower (k=215, k=119.3, k=87.3) than the decrease in morbidity (k = -250, k = -134.8, k = -108.5). The coefficients of the trend lines of increased mortality from COVID-19 were greater (from k = 20 to k = 162) than the decrease (from k = -15.3 to k = -29), and in interepidemic periods, morbidity (from k=-5 to k=-10.5) and mortality (from k = -1.6 to k = -19.8). The first interepidemic period was shorter and higher in morbidity and mortality than the subsequent ones. The incidence rates, as well as the coefficients of the trend lines of increased incidence, were higher in the North-Western, Far Eastern, Siberian and Ural Federal Districts than in Central, Volga, Southern, and North Caucasian. During periods of epidemics, there was a tendency for the proportion of children to increase among those who became ill, especially 7–14 years old (k = 1), and among those who died – people over 65 years old (k = 1.6), and in inter-epidemic periods, the proportion of people aged 15 –64 years (k = 2) and children 0 –2 years (k = 1.5), and among the deceased – the proportion of people aged 15–64 years (k = 2.5). 
Conclusions. The predominant development of the COVID-19 epidemics in the autumn-winter seasons (6 versus 3), the high intensity of the epidemics of the autumn-winter season in terms of duration and incidence over the entire period and at its peak, and the presence of 4 inter-epidemic periods (3 of them in summer) indicate the seasonal nature of the COVID-19. 

About the Authors

L. S. Karpova
The Federal State Budgetary Institution «Smorodintsev Research Influenza Institute» of Ministry of Healthcare of the Russian Federation
Russian Federation

Ludmila S. Karpova – Dr. Sci. (Med.), head of laboratory

Saint-Petersburg

+7 (812) 499-15-33



M. Yu. Pelikh
The Federal State Budgetary Institution «Smorodintsev Research Influenza Institute» of Ministry of Healthcare of the Russian Federation
Russian Federation

Maria Yu. Pelikh  – Researcher

Saint-Petersburg

+7 (812) 499-15-32



K. M. Volik
The Federal State Budgetary Institution «Smorodintsev Research Influenza Institute» of Ministry of Healthcare of the Russian Federation
Russian Federation

Ksenia M. Volik– lead programmer

Saint-Petersburg

+7 (911) 913-23-3



K. A. Stolyarov
The Federal State Budgetary Institution «Smorodintsev Research Influenza Institute» of Ministry of Healthcare of the Russian Federation
Russian Federation

Kirill A. Stolyarov – lead programmer

Saint-Petersburg

+7 (911) 218-32-43



N. M. Popovtseva
The Federal State Budgetary Institution «Smorodintsev Research Influenza Institute» of Ministry of Healthcare of the Russian Federation
Russian Federation

Nina M. Popovtseva – technician

Saint-Petersburg

+7 (812) 499-15-32



D. A. Lioznov
The Federal State Budgetary Institution «Smorodintsev Research Influenza Institute» of Ministry of Healthcare of the Russian Federation
Russian Federation

Dmitry A. Lioznov – Dr. Sci. (Med.), professor, director

Saint-Petersburg

+7 (812) 499-15-00



References

1. Salim SAK, Quarraisha AK. Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic. Loncet. Volume 398, lssue 10317, 11-17 December 2021, Poges 21262128. DOI:https://doi.org/10.1016/S0140-6736(21)02758-6

2. Bolze A., Luo Sh, White S, et al. SARS-CoV-2 Variant Delta Rapidly Displaced Variant Alpha in the United States and Led to Higher Viral Loads. Cell Reports Medicine 3, 100564, March 15, 2022

3. WHO -World Health Organization 2022-03-04 14:22:36 Statement on the VA subline.2 omicron options https://www.who.Int/ru/news/item/22-02-2022-statement-on-omicron-sublineage-ba.2

4. ECDC 2022. Situation updates on COVID-19. Variants of concern Available at https://www.ecdc.Europa.eu/en/covid-19/variants-concern

5. Kotov I.A., Agletdinov M.R., Roev G.V. et al Genomic surveillance of SARS-CoV-2 in Russia: insights from the VGARus platform. Journal of microbiology, epidemiology and immunobiology.2024;101(4):435–447. DOI:https://doi.org/10.36233/0372-9311-554 EDN: https://www.elibrary.ru/irjxcx

6. Gerasimov A.N., Voronin E.M., Melnichenko Yu.R. et al Methodology for assessing the basic reproductive number of relevant variants of the SARS-CoV-2 virus in Epidemiology and Vaccine Prevention 2024;23(4):12–22. DOI:https://doi.org/10.31631/2073-3046-2024-23-4-12-22

7. Starodubov V.I., Beregovykh V.V., Akimkin V.G., et al. Covid-19 in Russia: Evolution of Views on the Pandemic (Part 1) Bulletin of the Russian Academy of Medical Sciences.2022.- Vol. 77, No. 3, pp. 199–207. doi:10.15690/vramn2118

8. stopkoronavirus.ru

9. Akimkin V.G., Popova A.Yu., Ploskireva A.A., et al. COVID-19: the evolution of the pandemic in Russia. Report I: manifestations of the COVID-19 epidemic process. Journal of microbiology, epidemiology and immunobiology = Zhurnal mikrobiologii, èpidemiologii i immunobiologii. 2022;99(3):269–286. DOI: https://doi.org/10.36233/0372-9311-276

10. Gushchin V.A., Pochtovyi A.A., Kustova D.D., et al. Characterisation of the COVID-19 epidemic process in Moscow and search for possible determinants of the trends of the observed changes // Journal of microbiology, epidemiology and immunobiology. - 2023. - Vol. 100. - N. 4. - P. 267–284. doi: 10.36233/0372-9311-375. EDN: https://www.elibrary.ru/pvnhvz

11. Platonova T.A., Golubkova A.A., Smirnova S.S., et al. COVID-19 epidemic process in the Russian Federation: determinants and manifestations. Infektsionnye bolezni: novosti, mneniya, obuchenie [Infectious Diseases: News, Opinions, Training]. 2023; 12 (3): 8–17. DOI: https://doi.org/10.33029/2305-3496-2023-12-3-8-17 (in Russian)

12. Platonova T.A., Golubkova A.A., Smirnova S.S., et al. The epidemic process of a new coronavirus infection in Russia: manifestations and determinants. 2023. Т. 25. № 2. С. 161. https://doi.org/10.3390/v15071415

13. Fomicheva A.A., Pimenov N.N., Komarova S.B. et al. Features of the covid-19 epidemic and characteristics of patients during the spread of the delta SARS-COV-2 in the Russia Journal of Infectology 2024, Т.16.№3, DOI:10.22625/2072-6732-2024-16-3-45-55

14. Fomicheva A.A., Pimenov N.N., Komarova S.B. et al. Epidemiological features of the COVID-19 and characteristics of patients during the spread of the Omicron SARSCOD-2 in the Russia Epidemiology and Vaccinal Prevention.2023; 23(4):116–127.https://doi.org/10.31631/2073-3046-2024-23-4-116-127

15. Karpova L.S., Pelikh M.Yu., Popovtseva N.M., et аl. Coronavirus infection caused by the «omicron» variant and its daughter genovariants in Russia (2022-2023) Epidemiology and Vaccinal Prevention. 2024;23(2):36–49.https://doi.org/10.31631/2073-3046-2024-23-2-36-49

16. Briko N.I., Korshunov V.A., Krasnova S.V., et al. Clinical and epidemiological characteristics of hospitalized patients with COVID-19 during different pandemic periods in Moscow. Journal of microbiology, epidemiology and immunobiology = Zhurnal mikrobiologii, èpidemiologii i immunobiologii. 2022;99(3):287–299 DOI: https://doi.org/10.36233/0372-9311-272 EDN: https://elibrary.ru/iwbqxv

17. Akimkin V.G., Popova A.Yu., Khafizov K.F.F., and others. COVID-19: the evolution of the pandemic in Russia. Message II: the dynamics of the circulation of SARS-CoV-2 virus genovariants. Journal of Microbiology, Epidemiology and Immunobiology 2022 ;99 (4): 381–96. DOI:https://doi.org/10.36233/0372-9311-295 EDN:https://elbrary.ru/kvulas

18. Chernyavskaya OP, Kolodina DV, Belova TR. Similarities and differences in the manifestations of the COVID – 19 epidemic process in some countries. Epidemiology and Vac-cinal Prevention. 2023;22(5):96–109 (In Russ.). https://doi:10.31631/2073-3046-2023-22-5-96-109

19. Yakovlev A.A., Shafigullin A.V., Popov A.F., Shchelkanov M.Y. Dynamics of the epidemic process of COVID-19 and other acute respiratory viral infections in the Russian Far East (2019-2023) Epidemiology and Vaccinal Prevention 2025;24(1):18–30. DOI:https://doi.org/10.31631/2073-3046-2025-24-1-18-30


Review

For citations:


Karpova L.S., Pelikh M.Yu., Volik K.M., Stolyarov K.A., Popovtseva N.M., Lioznov D.A. Trends in the dynamics of morbidity and mortality from COVID-19 in Russia (2020-2025). Epidemiology and Vaccinal Prevention. 2025;24(5):4-­23. (In Russ.) https://doi.org/10.31631/2073-3046-2025-24-5-4-23

Views: 12


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2073-3046 (Print)
ISSN 2619-0494 (Online)